![ketamine-may-be-an-effective-treatment-for-children-with-adnp-syndrome-new-study-suggests](https://utterbuzz.com/wp-content/uploads/2022/09/ketamine-may-be-an-effective-treatment-for-children-with-adnp-syndrome-new-study-suggests-scaled.jpg)
Results of a small but unique research study suggest that low-dose ketamine is generally safe, well-tolerated and effective to treat clinical symptoms in children diagnosed with ADNP syndrome (also known as Helsmoortel-VanDerAa syndrome), a rare neurodevelopmental disorder caused by mutations in the activity dependent neuroprotective protein (ADNP) gene.